LCM
SGMT icon

Landscape Capital Management’s Sagimet Biosciences SGMT Stock Holding History

Landscape Capital Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,391
Closed -$174K – 886
2026
Q1 		$174K Buy
33,391
+7,490
+29% +$41.7K 0.01% 645
2025
Q4 		$153K Buy
25,901
+3,198
+14% +$23K 0.01% 635
2025
Q3 		$156K Buy
+22,703
New +$184K 0.01% 567

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Landscape Capital Management's SGMT Position: Q2 2026 in Review

Landscape Capital Management sold out of Sagimet Biosciences (SGMT) in Q2 2026, closing a stake of 33,391 shares — an estimated $174K sold.

Landscape Capital Management first reported a position in SGMT in Q3 2025 and held it in 3 quarters. The position peaked at $174K in Q1 2026. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Landscape Capital Management reported no remaining Sagimet Biosciences position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 33,391 Sagimet Biosciences shares in Q2 2026, an estimated $174K.
  • Landscape Capital Management first reported a position in Sagimet Biosciences in Q3 2025 and held it in 3 quarters.
  • Landscape Capital Management's Sagimet Biosciences position peaked at $174K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.